These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 22832731
1. Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies. Aoki Y, Kasai K, Yamasue H. Transl Psychiatry; 2012 Jan 17; 2(1):e69. PubMed ID: 22832731 [Abstract] [Full Text] [Related]
4. Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A. Psychiatry Res; 2006 Dec 01; 148(2-3):111-20. PubMed ID: 17088051 [Abstract] [Full Text] [Related]
5. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Yildiz-Yesiloglu A, Ankerst DP. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):969-95. PubMed ID: 16677749 [Abstract] [Full Text] [Related]
7. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders. Gabis L, Wei Huang, Azizian A, DeVincent C, Tudorica A, Kesner-Baruch Y, Roche P, Pomeroy J. J Child Neurol; 2008 Jul 30; 23(7):766-74. PubMed ID: 18487520 [Abstract] [Full Text] [Related]
8. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome. Śmigielska-Kuzia J, Boćkowski L, Sobaniec W, Kułak W, Sendrowski K. Pharmacol Rep; 2010 Jul 30; 62(6):1070-7. PubMed ID: 21273664 [Abstract] [Full Text] [Related]
9. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation. Auer DP, Wilke M, Grabner A, Heidenreich JO, Bronisch T, Wetter TC. Schizophr Res; 2001 Oct 01; 52(1-2):87-99. PubMed ID: 11595395 [Abstract] [Full Text] [Related]
13. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B. J Psychiatr Res; 2007 Oct 01; 41(8):625-34. PubMed ID: 16949099 [Abstract] [Full Text] [Related]